Dr. Prism Schneider, MD
Claim this profileFoothills Medical Centre
Studies Osteoarthritis
Studies Subtrochanteric Fracture
9 reported clinical trials
13 drugs studied
Affiliated Hospitals
Clinical Trials Prism Schneider, MD is currently running
Fixation vs. Removal
for Broken Bones
This study is a multicenter prospective randomized control trial comparing hardware retention (HR) to removal of hardware (RH).
Recruiting1 award N/A
Oral Blood Thinners
for Hip Fracture
As our Canadian population ages, hip fractures in these older adults are becoming very common. The best treatment for the majority of these injuries is urgent treatment with surgery. However, the hip fracture itself, the surgery required, and the immobility following these injuries are all risk factors for developing blood clots in the legs (deep vein thrombosis or DVT) and blood clots in the lungs (pulmonary embolism or PE). These complications are a common cause of death in patients with hip fractures and often result in prolonged medical treatment and hospital stays. Patients with hip fractures who require surgery are traditionally given injectable blood thinners to help prevent blood clots; however, these medications are costly, may not be tolerated well, and can be difficult to take, as prescribed. Oral blood thinning medications are being used more commonly, but it is unknown which of these medications is the most effective in preventing blood clots in patients after a hip fracture. Thrombelastography (TEG) technology uses a small sample of blood to evaluate a person's clotting ability. Our research has used TEG technology to evaluate blood clotting risk after hip fracture surgery and the investigators have found that platelets may play an important role in abnormal blood clotting after a hip fracture. The investigators have also shown that acetylsalicylic acid (ASA or Aspirin) may help reduce the abnormal platelet hyperactivity associated with blood clotting. This medication warrants investigation for blood clot prevention after hip fracture. The investigators propose to directly compare different oral medication regimens after hip fracture surgery, in order to determine which is safest and most effective in preventing blood clots. Our multi-disciplinary research team includes physicians, surgeons, and scientists with experience evaluating different medications for blood clot prevention. Our results will help determine the best medical treatment for preventing DVT and PE, which will benefit patients with hip fractures worldwide.
Recruiting1 award Phase 2
More about Prism Schneider, MD
Clinical Trial Related6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Prism Schneider, MD has experience with
- Acetylsalicylic Acid (ASA) 81mg Oral Tablet
- Rivaroxaban 10mg
- Hardware Removal
- Cognitive Behavioural Therapy
- Implant Removal
- Lactose Placebo
Breakdown of trials Prism Schneider, MD has run
Osteoarthritis
Subtrochanteric Fracture
Hip Fracture
Tarsometatarsal Joint Fracture Dislocation
Tarsometatarsal Joint Dislocation/Fracture
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Prism Schneider, MD specialize in?
Prism Schneider, MD focuses on Osteoarthritis and Subtrochanteric Fracture. In particular, much of their work with Osteoarthritis has involved treating patients, or patients who are undergoing treatment.
Is Prism Schneider, MD currently recruiting for clinical trials?
Yes, Prism Schneider, MD is currently recruiting for 3 clinical trials in Calgary Alberta. If you're interested in participating, you should apply.
Are there any treatments that Prism Schneider, MD has studied deeply?
Yes, Prism Schneider, MD has studied treatments such as Acetylsalicylic acid (ASA) 81mg Oral Tablet, Rivaroxaban 10mg, Hardware removal.
What is the best way to schedule an appointment with Prism Schneider, MD?
Apply for one of the trials that Prism Schneider, MD is conducting.
What is the office address of Prism Schneider, MD?
The office of Prism Schneider, MD is located at: Foothills Medical Centre, Calgary, Alberta T2N 5A1 Canada. This is the address for their practice at the Foothills Medical Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.